Gesundheit, Arzneimittel, Wohlfahrtsökonomik, Extra-Welfarismus. - Since 1961 access to market for innovative pharmaceuticals was increasingly regulated. The first step was a simple registration procedure, followed by federal licensing in 1978. Since 1989 the licensing was complemented by price...

This report argues for adjustments to regulatory governance traditions so that necessary changes can take place more quickly, at least cost to the economy and with the participation of all relevant stakeholders.